To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Valo Health and Khosla Ventures-backed SPAC to merge
Boston-based Valo Health, a developer of an AI-driven drug discovery platform and Khosla Ventures Acquisition Co, a blank check company backed by Khosla Ventures, have agreed to merge.
